MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
12:38
Tourist rescued by the Prahova mountain rescuers in Bucegi after venturing on a difficult trail inadequately equipped
12:15
Israel has announced tenders for the construction of 1,200 housing units in the West Bank, drawing criticism from the United Kingdom, France, Germany, Italy, and Canada.
12:08
A charter plane crashed in Alaska, causing the death of eight people. The aircraft fell near a military radar station.
11:43
The Polish Prime Minister defends the saboteurs of the Nord Stream gas pipeline and criticizes Germany
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
